Robustness testing and optimization of an adverse outcome pathway on cholestatic liver injury

Genomic responses in mouse models poorly mimic human inflammatory diseases

Junhee Seok, H. Shaw Warren, Alex G. Cuenca et al. · Proceedings of the National Academy of Sciences · 2013 · 2.9K citations · Full text

Adverse Outcome Pathway (AOP) Development I: Strategies and Principles

Daniel L. Villeneuve, Doug Crump, Natàlia García‐Reyero et al. · Toxicological Sciences · 2014 · 680 citations · Full text

Interference with Bile Salt Export Pump Function Is a Susceptibility Factor for Human Liver Injury in Drug Development

Ryan E. Morgan, Michael Trauner, Carlo J. van Staden et al. · Toxicological Sciences · 2010 · 327 citations · Full text

Benchmark Compounds, Immunology, Pathology +21

In Vitro Inhibition of the Bile Salt Export Pump Correlates with Risk of Cholestatic Drug-Induced Liver Injury in Humans

Sarah Dawson, Simone H. Stahl, Nikki R. Paul et al. · Drug Metabolism and Disposition · 2011 · 313 citations · Full text

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Carmen G. Tag, Sibille Sauer-Lehnen, Sabine Weiskirchen et al. · Journal of Visualized Experiments · 2015 · 298 citations · Full text

Immunology, Gastroenterology, Pathology +26